fig1
![Efficacy and safety of generic daclatasvir + sofosbuvir ± ribavirin in treatment of genotype 3 infected hepatitis C patients - a real life experience from Pakistan](https://image.oaes.cc/ae47fc23-c3b2-4362-b889-03b042884a93/2915.fig.1.jpg)
Figure 1. Genotype 3 hepatitis C virus chronic liver disease patients attaining rapid virologic response (RVR), end of treatment response (ETR) and sustained virologic response (SVR) using generic sofosbuvir and daclatasvir
Figure 1. Genotype 3 hepatitis C virus chronic liver disease patients attaining rapid virologic response (RVR), end of treatment response (ETR) and sustained virologic response (SVR) using generic sofosbuvir and daclatasvir
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/